The American regulators recommend to put a temporary halt on the use of Johnson & Johnson vaccine in the vaccination campaign.
Reuters cited six cases of blood clots among patients who were vaccinated with this particular drug. All ladies are aged from 18 to 48. Six to thirteen days after the vaccination, blood clots appeared in their bodies. One patient deceased, and one more was hospitalized in grave condition.
Blood clots are considered an extremely rare side effect, US medical authorities say.
"Acting U.S. Food and Drug Administration Commissioner Janet Woodcock said the agency expected the pause to be a matter of days, and was aimed at providing information to healthcare providers on how to diagnose and treat the clots", reads the story.
The outlet cited Dr. Amesh Adalja, an infectious disease expert at the Johns Hopkins Center for Health Security in Baltimore. "Even if causally linked to the vaccine: 6 cases with about 7 million doses ... is not something to panic about. People are asking me if they should cancel their J&J vaccine appointments and I have told them not to but I know many will and this will stall progress in controlling the pandemic", he said.
After the report about blood clots, Johnson & Johnson company decided to delay the start of the use of their vaccine in Europe.